Bo Peng – InmunoES

Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2

16 de October de 202616 de October de 2026 by Bo Peng

Cellular & Molecular Immunology, Published online: 16 October 2026; doi:10.1038/s41423-026-01461-4Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2

Circulating cytokines as potential dynamic biomarkers of PD-1 blockade response and prognosis in non-small cell lung cancer

7 de September de 2026 by Bo Peng

Programmed death 1 (PD-1) inhibitors have transformed the treatment of advanced non-small cell lung cancer (NSCLC), but durable responses remain limited to a subset of patients. Conventional biomarkers, including PD-L1 expression and tumor mutational b…